Evidence map›Paper›PMID 26100894›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health.

Kathryn E Holt, Heiman Wertheim, Ruth N Zadoks, Stephen Baker, Chris A Whitehouse, David Dance, Adam Jenney, Thomas R Connor, Li Yang Hsu, Juliëtte Severin and 18 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 770 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
770citing papers in PubMed, 3 pooled it
27.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

770 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,264 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A systematic review of hypervirulentFrontiers in medicine · 2025
    Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Characterization ofMicrobiology spectrum · 2026
    Article
  16. A posttranslational modification of fimbriae drives pathogenicity inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

710 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 9 countries.

Kathryn E HoltDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; nrt@sanger.ac.uk kholt@unimelb.edu.au.
Heiman WertheimOxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, National Hospital for Tropical Diseases, Hanoi, Vietnam; Nuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, OX3 7BN Oxford, United Kingdom;
Ruth N ZadoksQuality Milk Production Services, Cornell University, Ithaca, NY 14853; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, G12 8QQ Glasgow, United Kingdom;
Stephen BakerThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam;
Chris A WhitehouseUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702;
David DanceNuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, OX3 7BN Oxford, United Kingdom; Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic;
Adam JenneyDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; Departmemt Infectious Diseases and Microbiology Unit, The Alfred Hospital, Melbourne, VIC 3004, Australia;
Thomas R ConnorPathogen Genomics, Wellcome Trust Sanger Centre, CB10 1SA Cambridge, United Kingdom; Cardiff University School of Biosciences, Cardiff University, Cardiff, Wales, CF10 3AX, United Kingdom;
Li Yang HsuDepartment of Medicine, National University Health System, Singapore 119228;
Juliëtte SeverinDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands;
Sylvain BrisseMicrobial Evolutionary Genomics, Institut Pasteur, CNRS, UMR3525, Paris, France;
Hanwei CaoDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; Peter Doherty Institute, The University of Melbourne, Parkville, VIC 3010, Australia;
Jonathan WilkschDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; Peter Doherty Institute, The University of Melbourne, Parkville, VIC 3010, Australia;
Claire GorrieDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; Peter Doherty Institute, The University of Melbourne, Parkville, VIC 3010, Australia;
Mark B SchultzDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia;
David J EdwardsDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia;
Kinh Van NguyenNational Hospital for Tropical Diseases, Hanoi, Vietnam;
Trung Vu NguyenNational Hospital for Tropical Diseases, Hanoi, Vietnam;
Trinh Tuyet DaoNational Hospital for Tropical Diseases, Hanoi, Vietnam;
Martijn MensinkQuality Milk Production Services, Cornell University, Ithaca, NY 14853;
Vien Le MinhThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA 94118-6215;
Nguyen Thi Khanh NhuThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia;
Constance SchultszThe Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; Academic Medical Center, University of Amsterdam, 1012 WX Amsterdam, The Netherlands;
Kuntaman KuntamanDepartment of Clinical Microbiology, Dr. Soetomo Academic Hospital - School of Medicine, Airlangga University, Surabaya, Jawa Timur, Indonesia;
Paul N NewtonNuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, OX3 7BN Oxford, United Kingdom; Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic;
Catrin E MooreNuffield Department of Clinical Medicine, Centre for Tropical Medicine, University of Oxford, OX3 7BN Oxford, United Kingdom; Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic;
Richard A StrugnellDepartment of Microbiology and Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; Peter Doherty Institute, The University of Melbourne, Parkville, VIC 3010, Australia;
Nicholas R ThomsonPathogen Genomics, Wellcome Trust Sanger Centre, CB10 1SA Cambridge, United Kingdom; Department of Pathogen Molecular Biology, The London School of Hygiene and Tropical Medicine, WC1E 7HT London, United Kingdom nrt@sanger.ac.uk kholt@unimelb.edu.au.
University of Melbourne · AUHospital for Tropical Diseases · VNPeter Doherty Institute · AUGenomics (United Kingdom) · GBMahosot Hospital · LAOxford University Clinical Research Unit · VNAirlangga University · IDCornell University · USErasmus MC · NLInstitut Pasteur · FRLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit · LANational University Health System · SGUnited States Army Medical Research Institute of Infectious Diseases · USUniversity of Amsterdam · NLUniversity of Glasgow · GBUniversity of Queensland · AU

Funding

Wellcome Trust 089275/H/09/ZWellcome Trust 089276Wellcome Trust 098051Wellcome Trust 100087
6 · The paper itself

Abstract

Klebsiella pneumoniae is now recognized as an urgent threat to human health because of the emergence of multidrug-resistant strains associated with hospital outbreaks and hypervirulent strains associated with severe community-acquired infections. K. pneumoniae is ubiquitous in the environment and can colonize and infect both plants and animals. However, little is known about the population structure of K. pneumoniae, so it is difficult to recognize or understand the emergence of clinically important clones within this highly genetically diverse species. Here we present a detailed genomic framework for K. pneumoniae based on whole-genome sequencing of more than 300 human and animal isolates spanning four continents. Our data provide genome-wide support for the splitting of K. pneumoniae into three distinct species, KpI (K. pneumoniae), KpII (K. quasipneumoniae), and KpIII (K. variicola). Further, for K. pneumoniae (KpI), the entity most frequently associated with human infection, we show the existence of >150 deeply branching lineages including numerous multidrug-resistant or hypervirulent clones. We show K. pneumoniae has a large accessory genome approaching 30,000 protein-coding genes, including a number of virulence functions that are significantly associated with invasive community-acquired disease in humans. In our dataset, antimicrobial resistance genes were common among human carriage isolates and hospital-acquired infections, which generally lacked the genes associated with invasive disease. The convergence of virulence and resistance genes potentially could lead to the emergence of untreatable invasive K. pneumoniae infections; our data provide the whole-genome framework against which to track the emergence of such threats.

Indexed as

Genetic VariationAnimalsAnti-Infective AgentsBacterial ProteinsCross InfectionDrug Resistance, Multiple, BacterialGenes, BacterialGenome, BacterialGenomicsHumansKlebsiella InfectionsKlebsiella pneumoniaePhylogenyPopulation DynamicsPublic HealthSequence Analysis, DNAAnti-Infective AgentsBacterial Proteinsantimicrobial resistancegenomicsKlebsiella pneumoniaepopulation structurevirulence

Identifiers

PMID26100894
PMCPMC4500264
OpenAlexW1895017250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.